226 related articles for article (PubMed ID: 30228269)
1. Implementation and benchmarking of a novel analytical framework to clinically evaluate tumor-specific fluorescent tracers.
Koller M; Qiu SQ; Linssen MD; Jansen L; Kelder W; de Vries J; Kruithof I; Zhang GJ; Robinson DJ; Nagengast WB; Jorritsma-Smit A; van der Vegt B; van Dam GM
Nat Commun; 2018 Sep; 9(1):3739. PubMed ID: 30228269
[TBL] [Abstract][Full Text] [Related]
2. Improved Intraoperative Detection of Ovarian Cancer by Folate Receptor Alpha Targeted Dual-Modality Imaging.
Hekman MCH; Boerman OC; Bos DL; Massuger LFAG; Weil S; Grasso L; Rybinski KA; Oosterwijk E; Mulders PFA; Rijpkema M
Mol Pharm; 2017 Oct; 14(10):3457-3463. PubMed ID: 28826214
[TBL] [Abstract][Full Text] [Related]
3. Costs and effects of intra-operative fluorescence molecular imaging - A model-based, early assessment.
Präger M; Kiechle M; Stollenwerk B; Hinzen C; Glatz J; Vogl M; Leidl R
PLoS One; 2018; 13(6):e0198137. PubMed ID: 29856875
[TBL] [Abstract][Full Text] [Related]
4. First-in-human study of PET and optical dual-modality image-guided surgery in glioblastoma using
Li D; Zhang J; Chi C; Xiao X; Wang J; Lang L; Ali I; Niu G; Zhang L; Tian J; Ji N; Zhu Z; Chen X
Theranostics; 2018; 8(9):2508-2520. PubMed ID: 29721096
[No Abstract] [Full Text] [Related]
5. Tumor-Specific Uptake of Fluorescent Bevacizumab-IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study.
Lamberts LE; Koch M; de Jong JS; Adams ALL; Glatz J; Kranendonk MEG; Terwisscha van Scheltinga AGT; Jansen L; de Vries J; Lub-de Hooge MN; Schröder CP; Jorritsma-Smit A; Linssen MD; de Boer E; van der Vegt B; Nagengast WB; Elias SG; Oliveira S; Witkamp AJ; Mali WPTM; Van der Wall E; van Diest PJ; de Vries EGE; Ntziachristos V; van Dam GM
Clin Cancer Res; 2017 Jun; 23(11):2730-2741. PubMed ID: 28119364
[No Abstract] [Full Text] [Related]
6. Back-Table Fluorescence-Guided Imaging for Circumferential Resection Margin Evaluation Using Bevacizumab-800CW in Patients with Locally Advanced Rectal Cancer.
de Jongh SJ; Tjalma JJJ; Koller M; Linssen MD; Vonk J; Dobosz M; Jorritsma-Smit A; Kleibeuker JH; Hospers GAP; Havenga K; Hemmer PHJ; Karrenbeld A; van Dam GM; van Etten B; Nagengast WB
J Nucl Med; 2020 May; 61(5):655-661. PubMed ID: 31628218
[TBL] [Abstract][Full Text] [Related]
7. Tracers for Fluorescence-Guided Surgery: How Elongation of the Polymethine Chain in Cyanine Dyes Alters the Pharmacokinetics of a Dual-Modality c[RGDyK] Tracer.
Buckle T; van Willigen DM; Spa SJ; Hensbergen AW; van der Wal S; de Korne CM; Welling MM; van der Poel HG; Hardwick JCH; van Leeuwen FWB
J Nucl Med; 2018 Jun; 59(6):986-992. PubMed ID: 29449447
[TBL] [Abstract][Full Text] [Related]
8. Intraoperative near-infrared fluorescence tumor imaging with vascular endothelial growth factor and human epidermal growth factor receptor 2 targeting antibodies.
Terwisscha van Scheltinga AG; van Dam GM; Nagengast WB; Ntziachristos V; Hollema H; Herek JL; Schröder CP; Kosterink JG; Lub-de Hoog MN; de Vries EG
J Nucl Med; 2011 Nov; 52(11):1778-85. PubMed ID: 21990576
[TBL] [Abstract][Full Text] [Related]
9. uPAR-targeted optical near-infrared (NIR) fluorescence imaging and PET for image-guided surgery in head and neck cancer: proof-of-concept in orthotopic xenograft model.
Christensen A; Juhl K; Persson M; Charabi BW; Mortensen J; Kiss K; Lelkaitis G; Rubek N; von Buchwald C; Kjær A
Oncotarget; 2017 Feb; 8(9):15407-15419. PubMed ID: 28039488
[TBL] [Abstract][Full Text] [Related]
10. Intraoperative indocyanine green fluorescence guidance for excision of nonpalpable breast cancer.
Liu J; Guo W; Tong M
World J Surg Oncol; 2016 Oct; 14(1):266. PubMed ID: 27756411
[TBL] [Abstract][Full Text] [Related]
11. Improved resection and prolonged overall survival with PD-1-IRDye800CW fluorescence probe-guided surgery and PD-1 adjuvant immunotherapy in 4T1 mouse model.
Du Y; Sun T; Liang X; Li Y; Jin Z; Xue H; Wan Y; Tian J
Int J Nanomedicine; 2017; 12():8337-8351. PubMed ID: 29200846
[TBL] [Abstract][Full Text] [Related]
12. The Sentinel Margin: Intraoperative
van Keulen S; Nishio N; Birkeland A; Fakurnejad S; Martin B; Forouzanfar T; Cunanan K; Colevas AD; S van den Berg N; Rosenthal E
Clin Cancer Res; 2019 Aug; 25(15):4656-4662. PubMed ID: 31142505
[TBL] [Abstract][Full Text] [Related]
13. Feasibility of ex vivo fluorescence imaging of angiogenesis in (non-) culprit human carotid atherosclerotic plaques using bevacizumab-800CW.
Huisman LA; Steinkamp PJ; Hillebrands JL; Zeebregts CJ; Linssen MD; Jorritsma-Smit A; Slart RHJA; van Dam GM; Boersma HH
Sci Rep; 2021 Feb; 11(1):2899. PubMed ID: 33536498
[TBL] [Abstract][Full Text] [Related]
14. Intraoperative imaging of folate receptor alpha positive ovarian and breast cancer using the tumor specific agent EC17.
Tummers QR; Hoogstins CE; Gaarenstroom KN; de Kroon CD; van Poelgeest MI; Vuyk J; Bosse T; Smit VT; van de Velde CJ; Cohen AF; Low PS; Burggraaf J; Vahrmeijer AL
Oncotarget; 2016 May; 7(22):32144-55. PubMed ID: 27014973
[TBL] [Abstract][Full Text] [Related]
15. Fluorescence-guided imaging for resection margin evaluation in head and neck cancer patients using cetuximab-800CW: A quantitative dose-escalation study.
Voskuil FJ; de Jongh SJ; Hooghiemstra WTR; Linssen MD; Steinkamp PJ; de Visscher SAHJ; Schepman KP; Elias SG; Meersma GJ; Jonker PKC; Doff JJ; Jorritsma-Smit A; Nagengast WB; van der Vegt B; Robinson DJ; van Dam GM; Witjes MJH
Theranostics; 2020; 10(9):3994-4005. PubMed ID: 32226534
[TBL] [Abstract][Full Text] [Related]
16. Intraoperative Tumor Detection Using a Ratiometric Activatable Fluorescent Peptide: A First-in-Human Phase 1 Study.
Unkart JT; Chen SL; Wapnir IL; González JE; Harootunian A; Wallace AM
Ann Surg Oncol; 2017 Oct; 24(11):3167-3173. PubMed ID: 28699134
[TBL] [Abstract][Full Text] [Related]
17. Image-guided surgery using near-infrared Turn-ON fluorescent nanoprobes for precise detection of tumor margins.
Blau R; Epshtein Y; Pisarevsky E; Tiram G; Israeli Dangoor S; Yeini E; Krivitsky A; Eldar-Boock A; Ben-Shushan D; Gibori H; Scomparin A; Green O; Ben-Nun Y; Merquiol E; Doron H; Blum G; Erez N; Grossman R; Ram Z; Shabat D; Satchi-Fainaro R
Theranostics; 2018; 8(13):3437-3460. PubMed ID: 30026858
[TBL] [Abstract][Full Text] [Related]
18. Panitumumab-IRDye800CW for Fluorescence-Guided Surgical Resection of Colorectal Cancer.
Marston JC; Kennedy GD; Lapi SE; Hartman YE; Richardson MT; Modi HM; Warram JM
J Surg Res; 2019 Jul; 239():44-51. PubMed ID: 30798171
[TBL] [Abstract][Full Text] [Related]
19. Molecular Fluorescence Endoscopy Targeting Vascular Endothelial Growth Factor A for Improved Colorectal Polyp Detection.
Tjalma JJ; Garcia-Allende PB; Hartmans E; Terwisscha van Scheltinga AG; Boersma-van Ek W; Glatz J; Koch M; van Herwaarden YJ; Bisseling TM; Nagtegaal ID; Timmer-Bosscha H; Koornstra JJ; Karrenbeld A; Kleibeuker JH; van Dam GM; Ntziachristos V; Nagengast WB
J Nucl Med; 2016 Mar; 57(3):480-5. PubMed ID: 26678613
[TBL] [Abstract][Full Text] [Related]
20. Threshold Analysis and Biodistribution of Fluorescently Labeled Bevacizumab in Human Breast Cancer.
Koch M; de Jong JS; Glatz J; Symvoulidis P; Lamberts LE; Adams AL; Kranendonk ME; Terwisscha van Scheltinga AG; Aichler M; Jansen L; de Vries J; Lub-de Hooge MN; Schröder CP; Jorritsma-Smit A; Linssen MD; de Boer E; van der Vegt B; Nagengast WB; Elias SG; Oliveira S; Witkamp AJ; Mali WP; Van der Wall E; Garcia-Allende PB; van Diest PJ; de Vries EG; Walch A; van Dam GM; Ntziachristos V
Cancer Res; 2017 Feb; 77(3):623-631. PubMed ID: 27879266
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
